All sickle cell disease articles
-
Business
UK becomes first country in the world to authorise a Crispr-based gene therapy
Treatment aims to cure patients with β-thalassaemia and sickle-cell disease
-
Opinion
Human genome editing in perspective
Ethical, cultural and safety considerations are high priorities for researchers
-
Business
FDA approves first sickle cell drug in almost two decades
Glutamine-based drug is the first approved for children over 5